Letters in Drug Design & Discovery (LDDD)

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Letters in Drug Design & Discovery (LDDD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Drug Design, Biochemistry in Drug Design, Toxicology, Pharmaceutics, Pharmacology, Molecular Pharmacology, Biochemistry, Genetics and Molecular Biology (General), Drug Discovery, Toxicology and Pharmaceutics (General) , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1570-1808, E-ISSN: 1875-628X, Established: 2004, Impact Factor: 1.2
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE